Rheumatoid Arthritis (RA): Optimizing Pharmacotherapeutic Management Strategies
Cost: FreeView Offer chevron_right
Some have suggested that criteria for the diagnosis of Rheumatoid Arthritis used for the past two decades are inadequate for addressing the disease burden of RA because by the time a physician detects rheumatoid nodules or radiographic erosion, the optimal time has passed for treatment initiation, representing a gap in care relating to diagnosis of disease.
By the end of Rheumatoid Arthritis (RA): Optimizing Pharmacotherapeutic Management Strategies, you will be able to:
• Describe the pathophysiology of RA such that it might inform treatment mechanisms.
• Describe professional guideline recommendations’ approaches to the diagnosis and treatment of RA and, where applicable, apply them to patient cases
• Identify the currently available and emerging pharmacotherapeutic treatments for management of RA and apply them to patient cases using evidence-based medicine.
• Evaluate a treatment plan for a specific patient with RA to optimize safety and efficacy, suggesting modifications for improvement, including the management of comorbidities.
• Describe the challenges and barriers to care associated with treating patients with RA.
Rheumatologists and primary care physicians; physician assistants, nurse practitioners, nurses, and pharmacists who practice in rheumatology; and any other health care providers with an interest in or who clinically encounter patients with RA.